Universite Paris-Est Creteil Val de Marne, INSERM and CNRS patent heme oxygenase activators April 18, 2017
FDA clears Recardio's IND for development of dutogliptin for acute myocardial infarction March 30, 2017
Levosimendan does not result in lower 30-day mortality in high risk cardiac surgery patients March 28, 2017
Bristol-Myers Squibb synthesizes novel myeloperoxidase and/or eosinophil peroxidase inhibitors March 24, 2017
Toxicity and pharmacokinetics of myocardial infarction candidate RUC-4 studied in vivo March 24, 2017
Bristol-Myers Squibb divulgues myeloperoxidase and/or eosinophil peroxidase inhibitors March 23, 2017
RSS